A novel fusion partner for highly efficient and safe vaccines

• 收藏
• 分享

专利权人:

Theravac Pharmaceuticals AB

发明人:

Lars Hellman,Anna-Karin Olsson,Falk Saupe

申请号：

SE1500434

公开号：

SE1500434A1

申请日:

2015.10.29

申请国别(地区):

SE

年份:

2017

代理人:

摘要：

The invention relates to the use of the C terminal region of Lamprey or Hagfish variable leukocyte receptor (VLR) as fusion partner in various vaccine antigens to be used in therapeutic or preventive vaccine formulations for the treatment of inflammatory, autoimmune conditions or cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/